+1-617-394-8820 contact@baybiosciences.com

Bay Biosciences provides high quality, clinical grade, Pap smear samples with matched frozen sera (serum),  K2-EDTA plasma and peripheral blood mononuclear cells (PBMC) samples from unique cervical cancer patients.

The sera (serum), K2-EDTA plasma and PBMCs are processed from cervical cancer patient’s peripheral whole-blood using customized collection and processing protocols.

Pap Smear Overview

A Pap smear is a screening tool that doctors use detect abnormal cells and cancer. During the Pap smear, a healthcare professional takes a cell sample from the cervix.

Cervical cancer is a type of cancer that develops in the cells in the lower part of the uterus. This region is called the cervix, it is small and narrow, and it connects the uterus to the vagina. Also, it provides an entry for sperm to pass into the uterus. The cervix also provides an exit from the uterus for monthly menstrual blood flow or a baby during delivery.

Two Parts of Cervix

There are two parts to the cervix, and two different types of cells occur there:

Endocervix: This is the innermost part of the cervix. It lines the “tunnel” leading from the uterus into the vagina. It contains tall, column-like cells that are responsible for mucus secretion.

Ectocervix: This is the outer portion of the cervix, and it protrudes into the vagina. The ectocervix is home to squamous cells, which resemble fish scales under the microscope.

Where these two cell types meet is where most cervical cancers and precancerous cells form.


What is a Pap smear Test?

A Pap smear is a screening tool that can help doctors detect abnormal cells and cancer. It works by sampling cells from the cervix.

Although cervical cancer screening is vital for getting an early diagnosis of cervical cancer. However, with an early diagnosis, effective treatment is usually possible.

Types of Pap Smear Tests

Doctors recommend two tests for this purpose:

  • The Pap smear, which checks for abnormal cells.
  • Human papillomavirus (HPV) test, which detects DNA from HPV to reveal both its presence and type.

This information can help a doctor determine whether a person has cervical cancer, or if they have an increased risk of developing this disease.

These tests can detect:

  • Precancerous cell changes
  • The presence of HPV
  • Presence of cancer

If the tests lead to a diagnosis, a patient can then seek treatment.

Also, routine screening does not always automatically include both tests at the same time, but a person can ask for an HPV test at the same time as a Pap smear.

According to the American Cancer Society (ACS), deaths from cervical cancer decreased dramatically after the introduction of the Pap smear.


What Happens During a Pap Smear?

A doctor usually carries out a Pap smear during a gynecological pelvic exam. They insert a tool called a speculum into the vagina so that they can examine the cervix. Then, they take a sample of cervical cells using a brush or spatula and send them for testing.

Also, if possible, it is best to avoid having a Pap smear during a menstrual period, especially if the flow is heavy, as this can affect the results of the test. However, if a person only has the chance to have the test during menstruation, it is still better to attend than not.

While, a person should not douche or put anything in the vagina to clean it before the test. Doctors do not recommend douching at any time.


When to Have Pap Smear?

Recommendations on Pap smear frequency depend on several factors.

These include:

  • Age
  • Exposure to diethylstilbestrol (DES) when in the womb
  • HIV status
  • Medical history
  • Whether or not the person has a weakened immune system, for example, due to HIV
  • A female aged 21–29 years should have a Pap test every 3 years.
  • Women aged 30–65 years should have a Pap test every 3 years, or an HPV test every 5 years, or a Pap and HPV co-test every 5 years.

The American Cancer Society recommend that people between the ages of 25 and 65 should have an HPV test every five years.

After the age of 65 years, most women will not need a Pap smear or HPV test. However, each person’s risk factors vary.

Those who have had abnormal test results in the past and those who are sexually active with more than one partner may need more frequent testing.

After a total hysterectomy, which is the surgical removal of the uterus and cervix, a Pap smear will no longer be necessary.

Anyone who has a hysterectomy because they had cancerous or precancerous cells should continue to have regular tests.

Everyone has different needs, so it is important that people speak to their doctor about their risk factors for developing cervical cancer and their need for screening.

Pap Smear Results

The pap smear test results usually take 1–3 weeks to come back. Most test results are negative, but they can sometimes be positive. A positive result does not confirm that a person has cancer, but it indicates that more investigation is necessary.

Normal

In most Pap smears, the result is normal and does not reveal any abnormal cells.

Unclear

Sometimes the result is ambiguous. The doctor may ask the person to have more tests to monitor for any changes. These additional tests are likely to take place either soon after the first test or about 6 months later.

Abnormal

Sometimes the result is “abnormal.” The doctor may recommend more tests straight away or after 6 months depending on the extent of the cell changes.

Common cell abnormalities include the following:

Atypical squamous cells of undetermined significance (ASCUS): These are mildly abnormal cells that do not meet the criteria for precancerous cells. If HPV is present, the doctor may recommend additional testing.

Squamous intraepithelial lesion: These lesions indicate possible precancerous cellular changes that are likely to need further testing.

A doctor will usually recommend following up with a colposcopy, with or without a biopsy.

During a colposcopy, the doctor uses a colposcope to magnify the view of the cervix, vulva, and vagina for examination. They may take a biopsy sample for evaluation in a laboratory.

They are divided into two categories:

  • Low grade: A low-grade lesion has a low risk of progressing to cancer in the near future.
  • High grade: A high-grade lesion has a high risk of progressing to cancer sooner rather than later.
  • Atypical glandular cells: This diagnosis is indicative of abnormal cells in the endocervix. These will require further testing.
  • Squamous cell cancer or adenocarcinoma: This diagnosis signals the likelihood of cancer and depends on the cell type that is atypical. Further testing is required.

What Does an Abnormal Result Mean?

It is possible to classify the cell changes as follows:

Low-grade lesion: The risk of a low-grade lesion imminently progressing to cancer is minimal.

High-grade lesion: A high-grade lesion has a high likelihood of becoming cancerous sooner rather than later.

Atypical glandular cells: There are abnormal cells in the endocervix that will need further testing.

Squamous cell cancer or adenocarcinoma: There is a likelihood of cancer, depending on the type of cell that is atypical. Further testing is necessary.

Cervical Cancer Facts

In 2019, the ACS estimate that there will be around 13,170 new diagnoses of invasive cervical cancer in the United States and approximately 4,250 deaths.

Screening and other types of prevention can reduce this risk dramatically.

There are often no symptoms until the later stages, when there may be bleeding or discharge from the vagina. This is why it is important to attend screening.

Risk factors for developing cervical cancer include the following:

  • Not having the HPV vaccine
  • Having sex without using a condom
  • Not attending routine screenings
  • Having an HPV infection
  • Smoking
  • Having several sexual partners
  • Being overweight
  • Having a chlamydia infection
  • Using birth control pills for an extended period
  • Having a weakened immune system, for example, due to HIV
  • Not including enough fruit and vegetables in the diet
  • Using an intrauterine device (IUD) for birth control
  • Having several full-term pregnancies
  • Being under 18 years of age for the first full-term pregnancy
  • Taking the hormonal drug DES or having a mother who used it

Doctors also do not recommend douching, as this can increase the likelihood of exposing the vagina to bacterial infection.

What is human papillomavirus?

Human papillomavirus (HPV) is a virus that can lead to cervical cancer in some cases. There are over 150 types of HPV. Some types, for example, type 16 and 19, can lead to cervical cancer.

Other types can lead to different complications, such as noncancerous warts or papillomas.

HPV can pass from one person to another during vaginal, anal, or oral sex when there is skin-to-skin contact.

There is no cure, but the infection often resolves in time. However, if HPV becomes a long-term infection, the risk of cancer increases.

Treatment is available for HPV-related warts and cell changes.

Vaccination is available to protect against HPV infection. Until recently, the Centers for Disease Control and Prevention (CDC) have recommended that young women have the vaccine up to the age of 26 years and young men up to 21 years.

In 2018, however, the Food and Drug Administration (FDA) recommended a form of the vaccine called Gardasil 9, which protects against HPV, for men and women aged 27–45 years.

Outlook

Cervical cancer is a type of cancer that develops in the cervix. Before developing into cancer, cervical cells undergo abnormal changes that a Pap test can detect.

With early diagnosis and appropriate treatment, the chances of surviving cervical cancer are good.

If a doctor diagnoses cervical cancer in its earliest stage, the person has a 93-percent chance of surviving for at least 5 more years. However, if diagnosis occurs when cervical cancer is at the latest stage, the likelihood of survival falls to 15 percent.

The Office for Women’s Health note that cervical cancer is the “easiest gynelogical cancer to prevent,” as long as a person attends screening sessions and has the HPV vaccination.


Biospecimens

Bay Biosciences is a global leader in providing researchers with high quality, clinical grade, fully characterized human tissue samples, bio-specimens, and human bio-fluid collections.

Samples available include cancer (tumor) tissue, cancer serum, cancer plasma, cancer, peripheral blood mononuclear cells (PBMC). and human tissue samples from most other therapeutic areas and diseases.

Bay Biosciences maintains and manages its own bio-repository, the human tissue bank (biobank) consisting of thousands of diseased samples (specimens) and from normal healthy donors available in all formats and types.

In fact, our biobank procures and stores fully consented, de-identified and institutional review boards (IRB) approved human tissue samples and matched controls.

Our human tissue collections, specimens, and bio-fluids come with detailed patient clinical data associated with them.

So this critical patient’s clinical data includes information relating to their past and current disease, treatment history, lifestyle choices, biomarkers, and genetic information.

Additionally, new effective treatments (drug discovery & development) in oncology, and other therapeutic areas and diseases are identified by researchers using patient’s data which is extremely valuable.

Bay Biosciences banks wide variety of human tissue samples and biological samples, including cryogenically preserved at – 80°C.

For example fresh frozen tissue samplestumor tissue samples, formalin-fixed paraffin-embedded (FFPE), tissue slides, with matching human bio-fluids, whole blood and blood-derived products such as serumplasma and PBMC.

Bay Biosciences is a global leader in collecting and providing human tissue samples according to the specified requirements and customized, tailor-made collection protocols.

Please contact us anytime to discuss your special research projects and customized human tissue sample requirements.

Types of Biospecimens

Bay Biosciences provides human tissue samples (human specimens) from diseased and normal healthy donors which includes:

Moreover, we can also procure most human bio-specimens, special collections and requests for human samples that are difficult to find. All our human tissue samples are procured through IRB-approved clinical protocols and procedures.

In addition to the standard processing protocols, Bay Biosciences can also provide human plasmaserum, and PBMC bio-fluid samples using custom processing protocols; you buy donor-specific collections in higher volumes and specified sample aliquots from us.

Bay Biosciences also provides human samples from normal healthy donors; volunteers, for controls and clinical research, contact us Now.

  • 日本のお客様は、ベイバイオサイエンスジャパンBay Biosciences Japanまたはhttp://baybiosciences-jp.com/contact/までご連絡ください。